Tracing illicit and prescription drug use in a Spanish prison by combining wastewater analysis and pharmaceutical dispensing data

dc.contributor.affiliationUniversidade de Santiago de Compostela. Instituto de Investigación do Medio Acuático para Unha Saúde Global (iARCUS)
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Química Analítica, Nutrición e Bromatoloxía
dc.contributor.authorEgaña, Iker
dc.contributor.authorNogales-García, Maite
dc.contributor.authorAkhrimenko, Vladimir
dc.contributor.authorGonzález Gómez, Xiana
dc.contributor.authorRodil Rodríguez, María del Rosario
dc.contributor.authorMontes Goyanes, Rosa
dc.contributor.authorQuintana Álvarez, José Benito
dc.contributor.authorMestre-Pintó, Juan Ignacio
dc.contributor.authorOrive, Gorka
dc.contributor.authorLertxundi, Unax
dc.date.accessioned2026-04-20T12:36:53Z
dc.date.available2026-04-20T12:36:53Z
dc.date.issued2026-04-12
dc.description.abstractBackground and aim We combined wastewater-based epidemiology (WBE) and pharmaceutical dispensing records to distinguish between illicit and prescription drug use. Methods We collected 24-h composite wastewater samples during three one-week campaigns in a prison in northern Spain. Samples were analysed for pharmaceuticals, illicit drugs, nicotine and alcohol. Population-normalised daily loads (PNDLs) were converted to consumption estimates and compared with Spanish population WBE estimates and pharmacy dispensing data. Results Wastewater analysis showed high use of several pharmaceuticals, with the highest average PNDL for gabapentinoids. Pregabalin and gabapentin estimates from wastewater exceeded pharmacy dispensing, suggesting internal diversion. Cannabis consumption was about four times higher than community estimates and cocaine was also higher in all campaigns. Ketamine and MDMA use were above community medians during the February campaign and nicotine use was nearly ten times higher than community levels. Conclusion WBE identifies prescription drug diversion, illicit drug markets and quantifies licit substance use in prisons.
dc.description.peerreviewedSI
dc.description.sponsorshipThis work was financed by Instituto de Salud Carlos III (RD21/0009/0012, RD24/0003/0020 & RD24/0003/0001 – RIAPAd Network) and the Spanish Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 (RED2022–134363-T & PID2024–156804OB-C32), which were co-funded by the European Union (ERDF and/or Next Generation funds), Consellería de Cultura, Educación y Universidades da Xunta de Galicia (ED431C 2025/21), Fundación Vital (Vitoria-Gasteiz), and the Araba Mental Health Network.idered as potential competing interests:
dc.identifier.citationI. Egaña et al. Tracing illicit and prescription drug use in a Spanish prison by combining wastewater analysis and pharmaceutical dispensing data. Environmental Toxicoloy and Pharmacology 124 (2026) 105021. https://doi.org/10.1016/j.etap.2026.105021
dc.identifier.doi10.1016/j.etap.2026.105021
dc.identifier.essn1872-7077
dc.identifier.urihttps://hdl.handle.net/10347/46828
dc.issue.number124
dc.journal.titleEnvironmental Toxicology and Pharmacology
dc.language.isoeng
dc.page.initial105021
dc.publisherElsevier
dc.relation.publisherversionhttps://doi.org/10.1016/j.etap.2026.105021
dc.rights© 2026 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectWastewater based epidemiology
dc.subjectDrugs & prison
dc.subjectDrug trafficking
dc.subjectGabapentinoids
dc.subjectIllicit drugs
dc.subjectAlcohol
dc.titleTracing illicit and prescription drug use in a Spanish prison by combining wastewater analysis and pharmaceutical dispensing data
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublicationf9079fd6-969f-404b-bf70-98c2489c9ed7
relation.isAuthorOfPublicationa4157885-4219-4fe9-8eac-48d5a4d5945d
relation.isAuthorOfPublicationbcdb2d9f-0e35-4477-ad85-0e560b03b4a1
relation.isAuthorOfPublication.latestForDiscoveryf9079fd6-969f-404b-bf70-98c2489c9ed7

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
EnvironToxicolPharmacol_124_2026_105021.pdf
Size:
960.61 KB
Format:
Adobe Portable Document Format
Description:
Main article
Loading...
Thumbnail Image
Name:
EnvironToxicolPharmacol_124_2026_105021_SI.pdf
Size:
341.92 KB
Format:
Adobe Portable Document Format
Description:
Supporting Information